RBP7 and invasive breast carcinoma: Additionally, the results revealed that RBP7 mRNA expression levels were significantly lower in most cancer samples than their corresponding normal samples, including breast invasive carcinoma (BRCA), uterine corpus endometrial carcinoma (UCEC), and lung adenocarcinoma (LUAD).